Although our findings support the role of TREM2 in improving mitochondrial dysfunction for the treatment of neurodegenerative diseases and neuroinflammation, this study has limitations because of its in vitro nature, and cannot fully represent the actual situation in vivo. The gene discussed is TREM2; the disease is neurodegenerative disease.